Q32 Bio Inc. QTTB

Full chart Compare
Set alert

Price alert · QTTB

All alert types
8.97 USD 0.00 (+0.00%)

At closeNov 5, 2026, 8:59 AM EST

8.56 -0.41 -4.57%

Pre-market · Nov 5, 8:59 AM ET

Day range unavailable

1.91 52-week range 23.57
YTD
+170.18%
1 year
+275.31%

Financial health

Altman Z-Score

17.40 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

S-5 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 5

Valuation

P/E 1.4×
FY 2016: -86.8×FY 2017: -23.3×FY 2018: -11.5×FY 2019: -8.4×FY 2020: -4.0×FY 2021: -20.8×FY 2022: -6.3×FY 2023: -2.4×FY 2024: -0.7×FY 2025: 1.4×
FY 2016 5y median -2.4× FY 2025
P/S 0.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 120×FY 2019: 523×FY 2020: 192×FY 2021: 0.0×FY 2022: 40.7×FY 2023: -19.6×FY 2024: 0.0×FY 2025: 0.8×
FY 2016 5y median 0.0× FY 2025
P/B 1.0×
FY 2016: 93.1×FY 2017: 7.1×FY 2018: 3.3×FY 2019: 3.4×FY 2020: 2.6×FY 2021: 4.6×FY 2022: 1.5×FY 2023: -0.7×FY 2024: 5.7×FY 2025: 1.0×
FY 2016 5y median 1.5× FY 2025
P/FCF -1.2×
FY 2016: -66.7×FY 2017: 154×FY 2018: -9.5×FY 2019: -7.7×FY 2020: -5.3×FY 2021: -7.0×FY 2022: -20.1×FY 2023: -7.0×FY 2024: -0.5×FY 2025: -1.2×
FY 2016 5y median -7.0× FY 2025
EV/EBITDA 0.3×
FY 2016: -88.0×FY 2017: -22.1×FY 2018: -10.2×FY 2019: -8.4×FY 2020: -2.6×FY 2021: -25.7×FY 2022: -6.9×FY 2023: -3.3×FY 2024: 0.6×FY 2025: 0.3×
FY 2016 5y median -3.3× FY 2025
EV/Sales 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 113×FY 2019: 491×FY 2020: 117×FY 2021: 0.0×FY 2022: 40.1×FY 2023: -23.4×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
FCF Yield -82.1%
FY 2016: -1.5%FY 2017: 0.6%FY 2018: -10.6%FY 2019: -13.0%FY 2020: -18.9%FY 2021: -14.3%FY 2022: -5.0%FY 2023: -14.3%FY 2024: -211.4%FY 2025: -82.1%
FY 2016 5y median -14.3% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin 31.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1126.0%FY 2019: -6599.2%FY 2020: -4821.0%FY 2021: 0.0%FY 2022: -589.8%FY 2023: 725.5%FY 2024: 0.0%FY 2025: 31.5%
FY 2016 5y median 0.0% FY 2025
Net Margin 55.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1044.3%FY 2019: -6237.5%FY 2020: -4762.9%FY 2021: 0.0%FY 2022: -643.6%FY 2023: 808.0%FY 2024: 0.0%FY 2025: 55.5%
FY 2016 5y median 0.0% FY 2025
ROE 71.0%
FY 2016: -107.3%FY 2017: -30.5%FY 2018: -28.3%FY 2019: -40.2%FY 2020: -65.7%FY 2021: -22.1%FY 2022: -24.1%FY 2023: 29.4%FY 2024: -841.1%FY 2025: 71.0%
FY 2016 5y median -22.1% FY 2025
ROIC 29.5%
FY 2016: -127.5%FY 2017: -23.0%FY 2018: -25.3%FY 2019: -36.9%FY 2020: -53.5%FY 2021: -18.8%FY 2022: -18.9%FY 2023: -140.4%FY 2024: -83.1%FY 2025: 29.5%
FY 2016 5y median -18.9% FY 2025
ROA 48.3%
FY 2016: -56.6%FY 2017: -21.8%FY 2018: -21.5%FY 2019: -33.5%FY 2020: -48.8%FY 2021: -17.7%FY 2022: -18.7%FY 2023: -114.2%FY 2024: -51.7%FY 2025: 48.3%
FY 2016 5y median -18.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -68.7%FY 2020: 62.2%FY 2021: -100.0%FY 2022: 0.0%FY 2023: -200.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 125.6%
FY 2016: 0.0%FY 2017: -196.6%FY 2018: -102.1%FY 2019: -83.5%FY 2020: -18.5%FY 2021: 71.8%FY 2022: -6.9%FY 2023: -23.0%FY 2024: -37.0%FY 2025: 125.6%
FY 2016 FY 2025
EPS (diluted) 136.8%
FY 2016: 0.0%FY 2017: -272.6%FY 2018: -143.0%FY 2019: -26.7%FY 2020: -13.6%FY 2021: 93.8%FY 2022: -14.0%FY 2023: -25.6%FY 2024: -45.9%FY 2025: 136.8%
FY 2016 FY 2025
Free Cash Flow 50.5%
FY 2016: 0.0%FY 2017: 143.2%FY 2018: -1593.1%FY 2019: -67.7%FY 2020: 13.4%FY 2021: -14.4%FY 2022: 88.0%FY 2023: -39.0%FY 2024: -262.9%FY 2025: 50.5%
FY 2016 FY 2025

Financial Health

Current Ratio 4.9×
FY 2016: 1.9×FY 2017: 14.9×FY 2018: 9.8×FY 2019: 21.5×FY 2020: 9.7×FY 2021: 11.1×FY 2022: 7.7×FY 2023: 2.0×FY 2024: 5.0×FY 2025: 4.9×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 4.9×
FY 2016: 1.9×FY 2017: 14.9×FY 2018: 9.8×FY 2019: 21.5×FY 2020: 9.7×FY 2021: 11.1×FY 2022: 7.7×FY 2023: 2.0×FY 2024: 5.0×FY 2025: 4.9×
FY 2016 5y median 5.0× FY 2025
Debt / Equity 0.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.2×FY 2023: -0.3×FY 2024: 3.3×FY 2025: 0.4×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -1.1×
FY 2016: 1.5×FY 2017: 1.8×FY 2018: 0.7×FY 2019: 0.6×FY 2020: 1.7×FY 2021: 3.1×FY 2022: 0.1×FY 2023: -0.5×FY 2024: 1.3×FY 2025: -1.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 15.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -60.1×FY 2025: 15.4×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31